BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4...

Related Keywords

China ,Russia ,Ukraine ,United States ,America ,Troy Kirkpatrick ,Transjugular Intrahepatic Portosystemic ,Tom Polen ,Embecta Corp ,Revenue Growth ,Bd Life Sciences Revenues ,Bd Life Sciences ,Life Sciences ,Solutions Revenues ,Linkedin ,Diagnostics Solutions ,Medication Management Solutions ,Research Instruments ,Medication Delivery Solutions ,European Union Medical Device Regulation ,Casella Waste Systems Inc ,Bd Respiratory Viral Panel ,Catheter Solutions ,Exchange Commission ,Driving Durable ,Infusion System ,Stick Hospital ,Pro Needle Free Blood Collection Device ,Integrated Diagnostics Solutions ,Viral Panel ,Peripheral Intervention ,Transjugular Intrahepatic Portosystemic Shunt ,Stent Graft ,Best Code ,Corporate Citizens ,Casella Waste Systems ,Quarter Fiscal ,Diluted Earnings ,Organic Revenue Growth ,Base Revenues ,Months Ended September ,Organic Revenues ,Pharmaceutical Systems ,North America ,Vascular Access Management ,Pharmacy Automation ,Integrated Diagnostic Solutions ,Total Modular Track ,Specimen Management ,Clinical Reagents ,Critical Care ,Advanced Repair ,Infection Prevention ,Surgical Instrumentation ,Peripheral Vascular Disease ,Atherectomy System ,Targeted Temperature Management ,Digital Endoscope ,Full Year Fiscal ,Diabetes Care ,Devices Regulations ,Middle East ,Adam Reiffe ,Investor Relations ,Public Relations ,Discontinued Operations ,Diagnostic Testing ,Organic Revenue ,Continuing Operations ,Foreign Currency ,Bd Becton ,Ickinson And Company ,